ReadYourDNA

Propofol (Diprivan)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Propofol

What it is

Propofol is the most widely used intravenous anaesthetic: it strengthens GABA signalling and puts people to sleep within seconds, and they wake up quickly once it is stopped. It is used to start and maintain general anaesthesia, for sedation during procedures such as endoscopy, and in intensive care. Its milky appearance comes from the fat emulsion it is dissolved in. It is sold as Diprivan, among other names.

How genes come into it

Propofol is cleared mainly by UGT1A9 and by CYP2B6 and CYP2C9. Studies have linked CYP2B6 variants to its blood levels and the amount needed, and UGT1A9 to side effects; others looked at GABA receptor genes and ABCB1. The effects are small compared with age, weight and other medicines, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Propofol. Upload your DNA file to see which of these rows apply to you.

Rated evidence (5 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

UGT1A9 rs58597806: Level 3. Toxicity. 1.

CYP2B6 rs3745274: Level 3. Dosage. 1.

ADRB2 rs1042718: Level 3. Toxicity: Hypotensive disorder. 1.

ABCB1 rs1128503: Level 3. Efficacy. 1.

Metabolism (9 findings)

Studies of how quickly the body processes this medication.

CYP2B6 rs2279343: Genotypes AA + AG is associated with decreased clearance of propofol as compared to genotype GG.

CYP2C9 CYP2C9*1, CYP2C9*2: CYP2C9 *1/*1 + *1/*2 is associated with decreased concentrations of propofol in people with as compared to CYP2C9 *2/*2.

UGT1A9 rs2741045: Genotype CC is associated with increased clearance of propofol as compared to genotypes CT + TT.

UGT1A9 rs72551330: Genotype CT is associated with decreased clearance of propofol as compared to genotype TT.

Response (4 findings)

Studies of how well it worked in people carrying a variant.

ABCB1 rs1128503: Genotype GG is associated with increased response to propofol and remifentanil in children as compared to genotypes AA + AG.

ABCB1 rs1045642: Allele G is not associated with response to propofol and remifentanil in children as compared to allele A.

ABCB1 rs2032582: Allele C is not associated with response to propofol and remifentanil in children as compared to allele T.

ABCB1 rs2032582: Allele C is not associated with response to propofol and remifentanil in children as compared to allele A.

Dosing (3 findings)

Studies of how much of the drug people needed or tolerated.

CYP2B6 rs3745274: Genotypes GT + TT are associated with decreased dose of propofol as compared to genotype GG.

HTR2A rs6313: Genotype AA is associated with decreased dose of propofol as compared to genotypes AG + GG.

CYP2B6 CYP2B6 poor metabolizer: CYP2B6 intermediate metabolizer and poor metabolizer is not associated with decreased dose of propofol in people with Respiratory failure requiring assisted ventilation as compared to CYP2B6 normal metabolizer and ultrarapid metabolizer and rapid metabolizer.

Side effects (1 finding)

Studies of side effects in people carrying a variant.

CYP2B6 CYP2B6*1, CYP2B6*6: CYP2B6 *6 is associated with decreased response to propofol in people with Brain Injuries as compared to CYP2B6 *1.

Other findings (3 findings)

Studies that do not fall into the groups above.

GABRA1 rs2279020: Genotype GG is associated with increased response to propofol as compared to genotypes AA + AG.

GABRA2 rs11503014: Genotype CC is associated with decreased response to propofol as compared to genotypes CG + GG.

SCN9A rs6746030: Genotypes AA + AG are associated with increased response to propofol as compared to genotype GG.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Abilify (Antipsychotics)

Adderall (Stimulants)

Aimovig (CGRP Antagonists)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com